Audited —·Last updated 27 Jul 2026·5 citations·Tier 1·0 uses

Cholesterol Ratio Calculator

Calculate total-to-HDL and LDL-to-HDL ratios. Evaluate cardiovascular risk with primary-source lipid thresholds.

Cholesterol Ratio Calculator

LDL cholesterol
135
Total cholesterol to HDL ratio
4
LDL cholesterol to HDL ratio
2.4545

Background.

Lipid panels are among the most commonly ordered blood tests in preventive cardiology, yet the raw numbers—total cholesterol, HDL, LDL, and triglycerides—can be difficult for patients to interpret in isolation. A cholesterol ratio calculator that estimates LDL via the Friedewald equation and computes standard risk ratios provides an immediate, quantified picture of atherogenic burden. These ratios distill complex lipoprotein metabolism into single figures that clinicians have used for decades to stratify cardiovascular risk and guide statin therapy. The total-to-HDL ratio and LDL-to-HDL ratio are particularly powerful because they incorporate both atherogenic and protective lipoprotein fractions in one expression.

The demand for cholesterol calculation tools is steady, driven by annual physical examinations, insurance wellness screenings, and post-myocardial infarction follow-up. The American Heart Association recommends that adults aged 20 and older have a fasting lipid panel every four to six years, generating millions of results annually that patients subsequently research online. Primary care physicians use ratio calculators during consultations to illustrate why a patient with borderline LDL might still need therapy if HDL is low. Endocrinologists apply them in diabetic dyslipidaemia, where triglycerides are often elevated and the ratios reveal hidden risk. Insurance underwriters also use these metrics, alongside blood pressure and smoking status, to assign mortality risk classes.

The scientific history of LDL estimation began in 1972, when William Friedewald, Donald Levy, and Robert Fredrickson published a method to calculate LDL cholesterol from three readily measurable quantities: total cholesterol, HDL cholesterol, and triglycerides. Their derivation assumed that triglycerides divided by five approximated the cholesterol content of very-low-density lipoprotein (VLDL) in mg/dL. This assumption holds when triglycerides are below 400 mg/dL and the patient is not hyperchylomicronaemic. Before this equation, LDL measurement required ultracentrifugation, a technique available only in research laboratories. The Friedewald equation democratised LDL estimation and remains the standard of care in clinical chemistry today, though direct homogeneous LDL assays are increasingly common in large reference laboratories.

Ratio-based risk assessment has an equally robust pedigree. The Framingham Heart Study, initiated in 1948, demonstrated that the ratio of total cholesterol to HDL cholesterol predicted coronary heart disease more strongly than total cholesterol alone. A ratio below 3.5 is generally considered favourable, while ratios above 5.0 indicate elevated risk. More recent data from the INTERHEART study confirmed that apolipoprotein B-to-A1 ratios—which correspond closely to LDL-to-HDL ratios—were among the strongest modifiable risk factors for acute myocardial infarction across all inhabited continents. These epidemiological foundations explain why ratio calculators remain relevant even as direct LDL measurement becomes cheaper.

Cardiovascular disease remains the leading cause of mortality worldwide, responsible for an estimated 17.9 million deaths annually according to the World Health Organization. The 2022 European Society of Cardiology guidelines emphasize that lipid ratios complement absolute LDL targets in risk stratification, particularly for patients with metabolic syndrome or diabetes who frequently present with elevated triglycerides and low HDL. In resource-limited settings where direct LDL measurement is unavailable, the Friedewald equation and derived ratios offer a cost-effective method to identify individuals at high risk who would benefit from statin therapy. The WHO Global Action Plan for the Prevention and Control of NCDs includes a target of 25% relative reduction in premature cardiovascular mortality by 2025, a goal that depends partly on widespread adoption of simple risk-calculation tools in primary care.

What is cholesterol ratio calculator?

Cholesterol is a sterol lipid essential for cell membrane integrity, bile acid synthesis, and steroid hormone production. Because it is hydrophobic, it travels in blood packaged inside lipoprotein particles. Total cholesterol measures the sum of cholesterol carried by all lipoprotein classes. High-density lipoprotein (HDL) scavenges cholesterol from peripheral tissues and transports it to the liver for excretion, earning its designation as protective. Low-density lipoprotein (LDL) delivers cholesterol to peripheral tissues; when present in excess, it penetrates arterial intima and initiates atherosclerotic plaque formation. Triglycerides are the primary storage form of dietary fat and represent the main energy reserve.

The total-to-HDL cholesterol ratio is a unitless number obtained by dividing total cholesterol by HDL cholesterol. Values below 3.5 are associated with lower cardiovascular risk, while values above 5.0 suggest significantly elevated risk. The LDL-to-HDL ratio is similarly unitless and is considered optimal below 2.0, borderline between 2.0 and 3.0, and high above 3.0. These ratios are more stable across populations than absolute LDL values because they normalise for inter-individual variation in HDL metabolism. These ratios remain stable across fasting and non-fasting states because they are unitless, making them particularly useful in large epidemiological cohorts where standardised pre-analytical conditions are difficult to enforce.

How to use this calculator.

  1. Obtain a fasting lipid panel from a certified clinical laboratory.
  2. Enter total cholesterol in milligrams per decilitre (mg/dL).
  3. Enter HDL cholesterol in mg/dL.
  4. Enter triglycerides in mg/dL.
  5. Review the estimated LDL cholesterol calculated via the Friedewald equation.
  6. Review the total-to-HDL and LDL-to-HDL ratios.
  7. If triglycerides are 400 mg/dL or higher, recognise that the LDL estimate is unreliable and request direct LDL measurement.

The formula.

LDL = TC − HDL − TG ⁄ 5
TC · total cholesterol mg⁄dLHDL · HDL cholesterol mg⁄dLTG · triglycerides mg⁄dLTG ⁄ 5 · estimated VLDL cholesterolratios · TC ⁄ HDL and LDL ⁄ HDL

The Friedewald equation, LDL = TC − HDL − (TG / 5), rests on the lipoprotein composition of fasting serum. In normotriglyceridaemic individuals, very-low-density lipoprotein (VLDL) carries approximately five times as much triglyceride as cholesterol by mass. Therefore, dividing triglycerides by five yields an estimate of VLDL cholesterol. Subtracting HDL cholesterol and VLDL cholesterol from total cholesterol leaves the cholesterol carried by LDL particles. The equation assumes a constant triglyceride-to-cholesterol ratio in VLDL and the absence of chylomicrons, which is valid only in fasting samples with triglycerides below 400 mg/dL.

When triglycerides exceed 400 mg/dL, the VLDL composition assumption breaks down because remnant lipoproteins and chylomicrons contribute disproportionately to triglyceride mass. In such cases, the Friedewald equation systematically underestimates LDL cholesterol. The Martin-Hopkins modification addresses this by using a variable divisor based on triglyceride and non-HDL concentrations, but the classic equation remains the default in most clinical laboratories because it requires only three inputs. Dimensional analysis confirms that all terms are in mg/dL, yielding a result in mg/dL.

The total-to-HDL ratio is mathematically equivalent to the inverse of the HDL fraction of total cholesterol. Because HDL is inversely associated with risk, a higher denominator reduces the ratio and improves the risk profile. The LDL-to-HDL ratio contrasts the primary atherogenic particle with the primary anti-atherogenic particle. Research by Castelli et al. using Framingham data showed that this ratio predicted coronary events more accurately than LDL alone, particularly in women and older adults where absolute LDL levels can be misleadingly low. The LDL-to-HDL ratio gained additional prominence after the INTERHEART study demonstrated that apolipoprotein ratios were consistently more predictive of myocardial infarction than any single lipid fraction across 52 countries. This global validation established ratio-based risk assessment as a robust clinical tool transcending both ethnic and geographic variation across the diverse populations worldwide.

A worked example.

Example

A 48-year-old man receives a fasting lipid panel showing total cholesterol of 220 mg/dL, HDL of 55 mg/dL, and triglycerides of 150 mg/dL. To estimate LDL, first divide the triglyceride value by five, giving 30 mg/dL as the estimated VLDL cholesterol. Subtract HDL and this VLDL estimate from total cholesterol: 220 minus 55 minus 30 equals 135 mg/dL. The total-to-HDL ratio is 220 divided by 55, which equals 4.0. The LDL-to-HDL ratio is 135 divided by 55, which equals 2.45. An LDL of 135 mg/dL is above the optimal level of 100 mg/dL but below the 190 mg/dL threshold for very high risk. The total-to-HDL ratio of 4.0 indicates moderate atherosclerotic risk, suggesting that lifestyle modification and possibly statin therapy should be discussed with his physician, particularly if he has additional risk factors such as hypertension or a family history of premature coronary disease. Regular lipid monitoring every four to six months is recommended.

hdl55
tg150
tc220

Frequently asked questions.

Why does the Friedewald equation divide triglycerides by five?
The divisor of five reflects the average mass ratio of triglycerides to cholesterol in very-low-density lipoprotein particles in fasting normotriglyceridaemic serum. Friedewald, Levy, and Fredrickson derived this constant empirically in 1972 by comparing ultracentrifugation results with routine chemistry panels in 448 subjects. When triglycerides are below 400 mg/dL and chylomicrons are absent, VLDL carries roughly five times more triglyceride than cholesterol. Dividing by five therefore estimates VLDL cholesterol, which is then subtracted from total cholesterol along with HDL to isolate the LDL fraction. At higher triglyceride levels, remnant particles alter this ratio and the equation becomes inaccurate.
What is the difference between direct LDL and calculated LDL?
Direct LDL uses homogeneous assays that measure LDL cholesterol chemically without requiring the Friedewald calculation. These assays are accurate even when triglycerides exceed 400 mg/dL or when samples are non-fasting. Calculated LDL is an estimate derived from total cholesterol, HDL, and triglycerides. It is inexpensive, widely available, and sufficiently accurate for most routine screening. However, it systematically underestimates LDL in hypertriglyceridaemia and overestimates it when HDL is extremely low. Major guidelines allow either method for initial risk assessment, but direct measurement is preferred in diabetic patients with triglycerides above 250 mg/dL.
Is a high HDL always protective?
Not necessarily. While epidemiological studies consistently show an inverse association between HDL cholesterol and cardiovascular disease across population distributions, Mendelian randomisation studies suggest that simply raising HDL pharmacologically does not reduce events. Very high HDL levels above 100 mg/dL may even be associated with increased risk in some cohorts, possibly reflecting dysfunctional HDL particles that lose their anti-inflammatory and reverse cholesterol transport properties. The protective effect depends on HDL function—cholesterol efflux capacity—not merely concentration. Therefore, a high HDL should not be used to justify ignoring elevated LDL or other risk factors.
What triglyceride level invalidates the Friedewald equation?
The original 1972 publication recommended restricting the equation to triglycerides below 400 mg/dL. Above this threshold, chylomicron remnants and saturated VLDL particles distort the assumed 5:1 triglyceride-to-cholesterol ratio. More recent validation studies suggest that error increases measurably above 200 mg/dL in non-fasting samples and above 300 mg/dL in fasting samples. The 2018 AHA/ACC guideline notes that direct LDL measurement is preferred when triglycerides are 400 mg/dL or higher. The Martin-Hopkins equation offers an improved estimate by using a variable divisor, but it is not yet universally implemented in clinical laboratories.
What is a good total cholesterol to HDL ratio?
The Framingham Heart Study and subsequent guidelines consider a total-to-HDL ratio below 3.5 to be favourable and indicative of lower cardiovascular risk. Ratios between 3.5 and 5.0 suggest moderate risk, while ratios above 5.0 indicate high risk. For example, a patient with total cholesterol of 200 mg/dL and HDL of 40 mg/dL has a ratio of 5.0, placing them at elevated risk despite a total cholesterol that is not dramatically high. The ratio is particularly useful in women, who often have higher HDL levels and may appear low-risk based on total cholesterol alone despite having significant LDL elevation.
Can I calculate LDL without fasting?
The Friedewald equation requires fasting because postprandial chylomicrons increase triglycerides and violate the assumption that VLDL is the only triglyceride-rich lipoprotein. Non-fasting triglycerides can rise 20 to 100 mg/dL after a meal, causing calculated LDL to be artefactually low. Direct LDL assays can be performed non-fasting because they do not depend on the triglyceride value. The 2016 European Atherosclerosis Society consensus supports non-fasting lipid testing for screening, but if triglycerides are elevated, a fasting confirmatory panel is recommended for accurate LDL calculation.
Do cholesterol ratios replace absolute LDL targets?
No. Current AHA/ACC guidelines use absolute LDL thresholds—less than 100 mg/dL for optimal, less than 70 mg/dL for very high-risk patients—as the primary treatment targets. Ratios are supplementary tools that improve risk discrimination, particularly when absolute values are borderline. A patient with an LDL of 130 mg/dL and an HDL of 25 mg/dL has a much worse risk profile than a patient with the same LDL and an HDL of 65 mg/dL, and the ratio captures this distinction. Clinicians use ratios to refine risk discussion and shared decision-making, not to replace guideline-directed therapy thresholds.
What is non-HDL cholesterol and how does it relate to this calculator?
Non-HDL cholesterol equals total cholesterol minus HDL cholesterol. It includes LDL, VLDL, intermediate-density lipoprotein, and lipoprotein(a) cholesterol. Because it captures all atherogenic particles, some guidelines consider it superior to LDL alone in patients with elevated triglycerides. The Friedewald equation's first two terms—TC minus HDL—are exactly non-HDL cholesterol. Therefore, this calculator computes non-HDL as an intermediate step before subtracting TG/5. Non-HDL targets are 30 mg/dL higher than LDL targets; for example, a very high-risk patient aims for non-HDL below 100 mg/dL.
Are cholesterol ratios useful if I am already on a statin?
Yes. Cholesterol ratios help assess residual risk—the cardiovascular risk that persists despite achieving target LDL levels on statin therapy. Many patients on high-intensity statins reach an LDL of 70 mg/dL but still experience events because of low HDL or elevated triglycerides. The total-to-HDL and LDL-to-HDL ratios identify this residual risk and may prompt addition of ezetimibe, PCSK9 inhibitors, or fibrates. The IMPROVE-IT trial demonstrated that further reducing LDL below 70 mg/dL with ezetimibe provided additional benefit, supporting aggressive management even when ratios appear improved.

References& sources.

  1. [1]Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. (1972). "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge." Clin Chem 18(6):499-502.
  2. [2]Grundy, S.M., et al. (2019). "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." Circulation 139(25):e1082-e1143.
  3. [3]Castelli, W.P., et al. (1986). "Lipids and risk of coronary heart disease. The Framingham Study." Ann Epidemiol 4(2):151-157.
  4. [4]Yusuf, S., et al. (2004). "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study." Lancet 364(9438):937-952.
  5. [5]Centers for Disease Control and Prevention (2023). "Cholesterol Facts."
Related calculators
5
Blood Pressure CalculatorcarBMI CalculatorbodCalorie Burn CalculatorfitHbA1c CalculatorendTarget Heart Rate Calculatorfit

In this category

Embed

Quanta Pro

Paid features are coming later.

  • All 313 calculators remain free
  • No billing is enabled
Coming soon